Laman UtamaBLISSGVS • NSE
add
Bliss GVS Pharma Ltd
Tutup sebelumnya
₹163.84
Julat hari
₹160.00 - ₹165.99
Julat tahun
₹92.15 - ₹172.42
Permodalan pasaran
17.00B INR
Bilangan Purata
1.55J
Nisbah P/E
27.15
Hasil dividen
0.31%
Pertukaran utama
NSE
Berita pasaran
Kewangan
Penyata Pendapatan
Hasil
Pendapatan bersih
| (INR) | Sep 2024info | Perubahan T/T |
|---|---|---|
Hasil | 2.18B | 2.74% |
Perbelanjaan pengendalian | 682.58J | 6.38% |
Pendapatan bersih | 242.60J | -42.66% |
Margin untung bersih | 11.14 | -44.22% |
Pendapatan bagi setiap syer | — | — |
EBITDA | 414.11J | -23.69% |
Kadar cukai berkesan | 28.04% | — |
Kunci Kira-kira
Jumlah aset
Jumlah liabiliti
| (INR) | Sep 2024info | Perubahan T/T |
|---|---|---|
Pelaburan tunai dan jangka pendek | 2.20B | 34.93% |
Jumlah aset | 12.83B | 7.13% |
Jumlah liabiliti | 2.34B | 0.06% |
Jumlah ekuiti | 10.48B | — |
Syer tertunggak | 105.02J | — |
Harga kepada buku | 1.70 | — |
Pulangan pada aset | — | — |
Pulangan pada modal | 7.68% | — |
Aliran Tunai
Perubahan bersih dalam tunai
| (INR) | Sep 2024info | Perubahan T/T |
|---|---|---|
Pendapatan bersih | 242.60J | -42.66% |
Tunai daripada operasi | — | — |
Tunai daripada pelaburan | — | — |
Tunai daripada pembiayaan | — | — |
Perubahan bersih dalam tunai | — | — |
Aliran tunai bebas | — | — |
Perihal
Bliss GVS Pharma Limited is an Indian pharmaceutical company headquartered in Mumbai, India. Bliss GVS primarily develops, manufactures and markets products across various therapeutic categories including Anti-fungal, Contraceptive, Laxative, Anti-haemorrhoidal, Anti-spasmodic, Anti-malarial, Anti-biotic, Anti-microbial, Anti-inflammatory, Antipyretic, Analgesic and several others.
As of 31 March 2018, its market capitalization is INR 19.20 billion. Wikipedia
Diasaskan
1984
Tapak web
Pekerja
831
